Julia Neugebauer

1.0k total citations
23 papers, 520 citations indexed

About

Julia Neugebauer is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Julia Neugebauer has authored 23 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Julia Neugebauer's work include Cancer Cells and Metastasis (9 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Cancer Treatment Studies (4 papers). Julia Neugebauer is often cited by papers focused on Cancer Cells and Metastasis (9 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Cancer Treatment Studies (4 papers). Julia Neugebauer collaborates with scholars based in Germany, United States and France. Julia Neugebauer's co-authors include Ulrich Andergassen, Wolfgang Janni, Brigitte Rack, Michael Wilhelm, Monika Kasper-Sonnenberg, Axel Schölmerich, Jürgen Wittsiepe, Klaus Friese, Philip Hepp and Evgenij Fiškin and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Julia Neugebauer

23 papers receiving 513 citations

Peers

Countries citing papers authored by Julia Neugebauer

Since Specialization

Citations

This map shows the geographic impact of Julia Neugebauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Neugebauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Neugebauer more than expected).

Fields of papers citing papers by Julia Neugebauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Neugebauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Neugebauer. The network helps show where Julia Neugebauer may publish in the future.

Co-authorship network of co-authors of Julia Neugebauer

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Neugebauer. A scholar is included among the top collaborators of Julia Neugebauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Neugebauer. Julia Neugebauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustainable cascade reaction combining transition metal-biocatalysis and hydrophobic substrates in surfactant-free aqueous solutions 2023 ·Chemical Engineering Journal ·(unknown), (unknown), Julia Neugebauer, Didier Touraud, Fabrice Gallou, Werner Kunz	4
2	Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients 2018 ·NeuroImage Clinical ·Thomas J. Baumgarten, Julia Neugebauer, Georg Oeltzschner, (unknown), G. Kircheis, Dieter Häussinger, Joachim Lange, Hans-Jörg Wittsack, Markus Butz, Alfons Schnitzler	18
3	A cautionary tale of sense-antisense gene pairs: independent regulation despite inverse correlation of expression 2017 ·Nucleic Acids Research ·Ashish Goyal, Evgenij Fiškin, Tony Gutschner, Maria Polycarpou‐Schwarz, Matthias Groß, Julia Neugebauer, (unknown), Maïwen Caudron‐Herger, Vladimı́r Beneš, Sven Diederichs	62
4	Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients 2016 ·Oncology ·Brigitte Rack, (unknown), Elisabeth Trapp, Julia Jückstöck, Ulrich Andergassen, Julia Neugebauer, Bernd Kost, Tobias Weissenbacher, Udo Jeschke, Christian Schindlbeck, Wolfgang Janni, Marianna Alunni‐Fabbroni	15
5	Backbone circularization of Bacillus subtilis family 11 xylanase increases its thermostability and its resistance against aggregation 2015 ·Molecular BioSystems ·(unknown), (unknown), Constantin Ahlmann-Eltze, Jan Gleixner, Carolin Schmelas, (unknown), (unknown), Magdalena Büscher, Max Horn, (unknown), (unknown), Elisabeth Schäfer, (unknown), (unknown), Julia Neugebauer, Pierre Wehler, Matthias P. Mayer, Roland Eils, Barbara Di Ventura	20
6	Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer 2015 ·Translational Oncology ·Bernadette Jäger, (unknown), (unknown), (unknown), J Jueckstock, Ulrich Andergassen, Julia Neugebauer, Aurelia Pestka, Thomas W. P. Friedl, Udo Jeschke, Wolfgang Janni, Sophie Doisneau-Sixou, Brigitte Rack	13
7	Abstract P4-11-21: Prevalence of circulating tumor cells (CTCs) after five years of zoledronate treatment in the adjuvant SUCCESS-A study 2015 ·Cancer Research ·Brigitte Rack, Peter A. Fasching, Lothar Häberle, Thomas W. P. Friedl, Mahdi Rezai, J. Hilfrich, Hans Tesch, Georg Heinrich, Helmut Forstbauer, Julia Neugebauer, Elisabeth Trapp, Susanne Albrecht, Bernadette Jäger, Tanja Fehm, Volkmar Müller, Andreas Schneeweiß, Klaus Friese, W. Lichtenegger, Matthias W. Beckmann, Wolfgang Janni	1
8	Abstract P4-01-16: Detection of EMT, anoikis and stem cell markers in metastatic breast cancer patients under different lines of treatment 2015 ·Cancer Research ·Elisabeth Trapp, Brigitte Rack, (unknown), (unknown), Simone Hofmann, Thomas W. P. Friedl, Julia Neugebauer, Julia Jückstöck, Bernadette Jäger, Jens Huober, Wolfgang Janni, Marianna Alunni‐Fabbroni	1
9	The influence of low level pre- and perinatal exposure to PCDD/Fs, PCBs, and lead on attention performance and attention-related behavior among German school-aged children: Results from the Duisburg Birth Cohort Study 2014 ·International Journal of Hygiene and Environmental Health ·Julia Neugebauer, Jürgen Wittsiepe, Monika Kasper-Sonnenberg, (unknown), Axel Schölmerich, Michael Wilhelm	75
10	Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen 2014 ·International Journal of Cancer ·(unknown), (unknown), Laurent Devel, Fabrice Beau, Bertrand Czarny, (unknown), Julia Neugebauer, Vincent Dive, Peter Angel, Margareta M. Mueller	7
11	Evaluation of prevalence, number, and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in the SUCCESS A study. 2013 ·Journal of Clinical Oncology ·(unknown), Julia Neugebauer, Ulrich Andergassen, Bernadette Jaeger, J Jueckstock, Peter A. Fasching, Lothar Haeberle, Thomas W. P. Friedl, Iris Schrader, A. Lorenz, Hans Tesch, Mahdi Rezai, (unknown), Andreas Schneeweiß, Matthias W. Beckmann, Klaus Pantel, Wolfgang Janni, Brigitte Rack	2
12	Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer — Evaluation of Several Markers with Real-Time Reverse Transcription-PCR 2013 ·International Journal of Molecular Sciences ·Ulrich Andergassen, Simone Hofmann, Alexandra C. Kölbl, Christian Schindlbeck, Julia Neugebauer, Stefan Hutter, (unknown), Matthias Ilmer, Klaus Friese, Udo Jeschke	13
13	Persistence of HER2 overexpression on circulating tumor cells in patients after systemic treatment for HER2-positive breast cancer: Follow-up results of the German Success B trial. 2013 ·Journal of Clinical Oncology ·Julia Neugebauer, Brigitte Rack, (unknown), Ulrich Andergassen, Aurelia Pestka, Peter A. Fasching, Thomas W. P. Friedl, (unknown), Michael Clemens, (unknown), Georg Heinrich, (unknown), Andreas Schneeweiß, Matthias W. Beckmann, Klaus Pantel, Wolfgang Janni	2
14	CTCs in Primary Breast Cancer (I) 2012 ·Recent results in cancer research ·Brigitte Rack, Ulrich Andergassen, Wolfgang Janni, Julia Neugebauer	13
15	Detection of circulating tumour cells on mRNA levels with established breast cancer cell lines 2012 ·Biomedical Reports ·(unknown), Alexandra C. Kölbl, Ulrich Andergassen, Stephan Hütter, Julia Neugebauer, (unknown), (unknown), Udo Jeschke, Klaus Friese, Brigitte Rack	2
16	Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR. 2012 ·PubMed ·(unknown), Alexandra C. Kölbl, Christian Schindlbeck, Julia Neugebauer, Sabine Heublein, Matthias Ilmer, Brigitte Rack, Klaus Friese, Udo Jeschke, Ulrich Andergassen	5
17	Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients 2011 ·Archives of Gynecology and Obstetrics ·Brigitte Rack, Julia Jückstöck, (unknown), Ulrich Andergassen, Julia Neugebauer, Philip Hepp, A. Schoberth, Doris Mayr, Thomas Zwingers, Christian Schindlbeck, Klaus Friese, Wolfgang Janni	39
18	High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation 2011 ·Molecules ·(unknown), Julia Neugebauer, (unknown), (unknown)	116
19	The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer 2010 ·Breast Care ·Brigitte Rack, Ulrich Andergassen, Julia Neugebauer, (unknown), Philip Hepp, Harald Sommer, W. Lichtenegger, Klaus Friese, Matthias W. Beckmann, (unknown), Hans Hauner, Wolfgang Janni	57
20	The Viral Oncoprotein LMP1 Exploits TRADD for Signaling by Masking Its Apoptotic Activity 2008 ·PLoS Biology ·Frank Schneider, Julia Neugebauer, (unknown), (unknown), (unknown), (unknown), Arnd Kieser	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact